Cloud-clone
SKU:PAC000Hu01
Polyclonal Antibody to Haptoglobin Related Protein (HPR)
Polyclonal Antibody to Haptoglobin Related Protein (HPR)
Couldn't load pickup availability
;Immunohistochemistry: 5-20µg/mL
;Immunocytochemistry: 5-20µg/mL
;Optimal working dilutions must be determined by end user.
Product No.
PAC000Hu01
Organism Species
Homo sapiens (Human)
Source
Polyclonal antibody preparation
Host
Rabbit
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
None
Immunogen
RPC000Hu01-Recombinant Haptoglobin Related Protein (HPR)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
0.5mg/ml
Organism Species More
Rattus norvegicus (Rat), Sus scrofa; Porcine (Pig)
Applications
WB,IHC
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a rabbit polyclonal antibody raised against HPR. It has been selected for its ability to recognize HPR in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.01-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Biology of Blood and Marrow Transplantation | Association of Plasma CD163 Concentration with De Novo–Onset Chronic Graft-versus-Host Disease pubmed:28455006 |
| Biology of Blood and Marrow Transplantation | Association of plasma CD163 concentration with de novo-onset chronic graft-versus-host disease 10.1016:j.bbmt.2017.04.019 |
Share
